✦ LIBER ✦

Empagliflozin as Add On to Basal Insulin for 78 Weeks Improves Glycemic Control with Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM)

✍ Scribed by Rosenstock, Julio; Jelaska, Ante; Wang, Fei; Kim, Gabriel; Broedl, Uli; Woerle, Hans J.; Bajaj, Harpreet Singh

Book ID: 122939467
Publisher: Canadian Diabetes Association
Year: 2013
Tongue: English
Weight: 51 KB
Volume: 37
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2013.08.093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pramlintide as an Adjunct to Basal Insul

Pramlintide as an Adjunct to Basal Insulin: Effects on Glycemic Control and Weight in Patients with Type 2 Diabetes Mellitus

✍ Cameron W. Lush; Tamara Darsow; Bei Zhang; Gayle Lorenzi; Juan P. Frias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-daily Human GLP-1 Analog, Compared with Insulin Glargine: All as Add-on to Metformin and a Sulfonylurea in Type 2 Diabetes.

✍ Schmitz, O.; Russell-Jones, D.; Vaag, A.; Sethi, B.K.; lalic, N.; Antic, S.; Zdr 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 702 KB

Transferring to insulin detemir from NPH

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE™

✍ A. Dornhorst; H.-J. Lüddeke; C. Koenen; M. Meriläinen; A. King; A. Robinson; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Continuous subcutaneous delivery of exen

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

✍ Henry, Robert R.; Rosenstock, Julio; Logan, Douglas; Alessi, Thomas; Luskey, Ken 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB